Myopathy

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

P
PhilipsNetherlands - Amsterdam
1 program
Nocturnal ventilationN/A1 trial
Active Trials
NCT01530841Completed32Est. May 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsNocturnal ventilation

Clinical Trials (1)

Total enrollment: 32 patients across 1 trials

NCT01530841PhilipsNocturnal ventilation

Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy

Start: Jul 2012Est. completion: May 201632 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space